About
Technology
Issues
FAQ
Links
Official Page
Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA).
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.